Global Reproductive Genetics Market Size, Share, and Forecast 2028

Summary

Report Description

The global reproductive genetics market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to the growing awareness towards genetic engineering in the developing countries, to get better. Additionally, growing reimbursement improvements for medical tests and initiative, running parallel to multiple investments by government organizations for developing new diagnostic centers, have significantly increased the demand for reproductive genetics across different parts of the globe. Additionally, significant growth in advanced testing along with increasing awareness among different age group women for leading safe life, are further expected to increase the demand for reproductive genetics, thereby fuelling the market growth through 2027. Furthermore, increasing focus on family planning, favorable regulations by the government, and advancements in different testing are further expected to increase the demand for reproductive genetics, thereby supporting the market growth. Similarly, advancement in geno9mic technologies and implementation of this technology in clinical medicine will enhance the usage in genetic disorder testing, carrier screening and identification of infertility which will further boost the growth of the market during the forecast period.

Increasing demand for Genetic Testing

Increasing demand for genetic testing of embryos, either during pregnancy or of those created through IVF to check for possible genetic disorders, are driving growth of reproductive genetics market. Increasing genetic testing for embryos through IVF technology, and several developments in genetic testing are making it possible to test for genetic disorders in artificial reproduction, which is driving the market growth during the forecast period. Reproductive genetics help to identify embryo’s defects so that parents can adopt alternative procedure like IVF thus increasing the healthy pregnancy and baby regardless of patient health, which will further boost the market during forecast period. According to Statista, as of 2019, the leading state by number of legal abortions in the United States was New York, which reported over 78 thousand abortions that year. Florida also reported over 71 thousand abortions, followed by Texas with over 57 thousand. There was a total of 630000 legal abortions in the United States in 2019.

Growing Advancement in Genomic Technologies

Increasing advancement in genomic technologies and further implementation of these technologies in clinical medicine have enhanced their usage in diagnosis of genetic disorders, carrier screening, and identification of cause of infertility, propelling the market growth in the forecast period. Some tests are much expensive which help couples from going ahead with the tests. However, with the decline in cost of sequencing and surge in mixed-ethnicity population, an increasing number of couples/individuals are expected to opt for the new procedure, which expected to drive the market growth during forecast period. Birth defects affect one in every 33 babies (about 3% of all babies) born in the United States each year.

Download Free Sample Report

Market Segmentation

The global reproductive genetics market can be segmented by component, by technology, by procedure type, by application and by region. Based on component, the market can be segmented into Laboratory Developed Tests, Kits & Assays, and Reagents & Consumables. Based on technology, the market can be segmented into Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, and Microarrays. Based on procedure type, the market can be differentiated into Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, and Infertility Genetic Testing. Based on application, the market can be grouped into Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global reproductive genetics market on account of increasing demand for genetic testing to identify genetic abnormalities in the country.

Recent Development.

In May 2021, Juno Diagnostics, Which is a company focusing on enhancing access to genetic health information, announced that closing of Series A financing round for USD 25 million led by Perceptive Xontogeny Venture (PXV) Fund. The fund will support product development, clinical validation studies, and commercial launch of JunoDx’s product offerings for non-invasive prenatal testing.
In March 2020, Agilent Technology announced the launch of three new microarrays for prenatal and postnatal research. The microarray includes updated clinically relevant content from respected databases. Progression of next-generation sequencing is uncovering new gene-disease associations and databases are rapidly evolving to include these discoveries.

Market Players

CooperSurgical, Inc., Centogene AG, Invitae Corporation, Illumina, Inc., Myriad Genetics, Inc., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Natera, Inc, Eurofins Scientific SE are some of the leading players operating in the Global Reproductive Genetics Market.

Attribute	Details
Base Year	2022
Historic Data	2018 – 2021
Estimated Year	2023
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	· By Method · By Hormone · By Region
Regional scope	North America; Europe; Asia Pacific; South America; Middle East & Africa
Country scope	United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Turkey; Egypt
Key companies profiled	CooperSurgical, Inc., Centogene AG, Invitae Corporation, Illumina, Inc.,Myriad Genetics, Inc., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Natera, Inc, Eurofins Scientific SE
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global reproductive genetics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

· Reproductive Genetics Market, By Component:

o Laboratory Developed Tests

o Kits & Assays

o Reagents & Consumables

· Reproductive Genetics Market, By Technology:

o Next Generation Sequencing

o Polymerase Chain Reaction

o In Situ Hybridization, Microarrays

· Reproductive Genetics Market, By Procedure Type:

o Carrier Screening

o Prenatal Screening

o Preimplantation Genetic Testing

o Infertility Genetic Testing

· Reproductive Genetics Market, By Application:

o Aneuploidy

o Single Gene Disorder

o Structural Chromosomal Abnormality

o Others

· Reproductive Genetics Market, By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ France

§ Germany

§ United Kingdom

§ Italy

§ Spain

o Asia Pacific

§ China

§ India

§ Japan

§ South Korea

§ Australia

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

§ Turkey

§ Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Reproductive Genetics Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Reproductive Genetics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Reproductive Genetics Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Component (Laboratory Developed Tests, Kits & Assays, Reagents & Consumables)

5.2.2. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays)

5.2.3. By Procedure Type (Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, Infertility Genetic Testing)

5.2.4. By Application (Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, Others)

5.2.5. By Region

5.2.6. By Company (2022)

5.3. Market Map

5.3.1. By Component

5.3.2. By Technology

5.3.3. By Procedure Type

5.3.4. By Application

5.3.5. By Region

6. North America Reproductive Genetics Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Component

6.2.2. By Technology

6.2.3. By Procedure Type

6.2.4. By Application

6.2.5. By Country

6.3. North America: Country Analysis

6.3.1. United States Reproductive Genetics Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Component

6.3.1.2.2. By Technology

6.3.1.2.3. By Procedure Type

6.3.1.2.4. By Application

6.3.2. Canada Reproductive Genetics Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Component

6.3.2.2.2. By Technology

6.3.2.2.3. By Procedure Type

6.3.2.2.4. By Application

6.3.3. Mexico Reproductive Genetics Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Component

6.3.3.2.2. By Technology

6.3.3.2.3. By Procedure Type

6.3.3.2.4. By Application

7. Europe Reproductive Genetics Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Component

7.2.2. By Technology

7.2.3. By Procedure Type

7.2.4. By Application

7.2.5. By Country

7.3. Europe: Country Analysis

7.3.1. France Reproductive Genetics Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Component

7.3.1.2.2. By Technology

7.3.1.2.3. By Procedure Type

7.3.1.2.4. By Application

7.3.2. Germany Reproductive Genetics Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Component

7.3.2.2.2. By Technology

7.3.2.2.3. By Procedure Type

7.3.2.2.4. By Application

7.3.3. United Kingdom Reproductive Genetics Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Component

7.3.3.2.2. By Technology

7.3.3.2.3. By Procedure Type

7.3.3.2.4. By Application

7.3.4. Italy Reproductive Genetics Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Component

7.3.4.2.2. By Technology

7.3.4.2.3. By Procedure Type

7.3.4.2.4. By Application

7.3.5. Spain Reproductive Genetics Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Component

7.3.5.2.2. By Technology

7.3.5.2.3. By Procedure Type

7.3.5.2.4. By Application

8. Asia-Pacific Reproductive Genetics Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Component

8.2.2. By Technology

8.2.3. By Procedure Type

8.2.4. By Application

8.2.5. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Reproductive Genetics Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Component

8.3.1.2.2. By Technology

8.3.1.2.3. By Procedure Type

8.3.1.2.4. By Application

8.3.2. India Reproductive Genetics Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Component

8.3.2.2.2. By Technology

8.3.2.2.3. By Procedure Type

8.3.2.2.4. By Application

8.3.3. Japan Reproductive Genetics Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Component

8.3.3.2.2. By Technology

8.3.3.2.3. By Procedure Type

8.3.3.2.4. By Application

8.3.4. South Korea Reproductive Genetics Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Component

8.3.4.2.2. By Technology

8.3.4.2.3. By Procedure Type

8.3.4.2.4. By Application

8.3.5. Australia Reproductive Genetics Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Component

8.3.5.2.2. By Technology

8.3.5.2.3. By Procedure Type

8.3.5.2.4. By Application

9. South America Reproductive Genetics Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Component

9.2.2. By Technology

9.2.3. By Procedure Type

9.2.4. By Application

9.2.5. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Reproductive Genetics Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Component

9.3.1.2.2. By Technology

9.3.1.2.3. By Procedure Type

9.3.1.2.4. By Application

9.3.2. Argentina Reproductive Genetics Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Component

9.3.2.2.2. By Technology

9.3.2.2.3. By Procedure Type

9.3.2.2.4. By Application

9.3.3. Colombia Reproductive Genetics Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Component

9.3.3.2.2. By Technology

9.3.3.2.3. By Procedure Type

9.3.3.2.4. By Application

10. Middle East and Africa Reproductive Genetics Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Component

10.2.2. By Technology

10.2.3. By Procedure Type

10.2.4. By Application

10.2.5. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Reproductive Genetics Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Component

10.3.1.2.2. By Technology

10.3.1.2.3. By Procedure Type

10.3.1.2.4. By Application

10.3.2. Saudi Arabia Reproductive Genetics Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Component

10.3.2.2.2. By Technology

10.3.2.2.3. By Procedure Type

10.3.2.2.4. By Application

10.3.3. UAE Reproductive Genetics Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Component

10.3.3.2.2. By Technology

10.3.3.2.3. By Procedure Type

10.3.3.2.4. By Application

10.3.4. Turkey Reproductive Genetics Market Outlook

10.3.4.1. Market Size & Forecast

10.3.4.1.1. By Value

10.3.4.2. Market Share & Forecast

10.3.4.2.1. By Component

10.3.4.2.2. By Technology

10.3.4.2.3. By Procedure Type

10.3.4.2.4. By Application

10.3.5. Egypt Reproductive Genetics Market Outlook

10.3.5.1. Market Size & Forecast

10.3.5.1.1. By Value

10.3.5.2. Market Share & Forecast

10.3.5.2.1. By Component

10.3.5.2.2. By Technology

10.3.5.2.3. By Procedure Type

10.3.5.2.4. By Application

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments

12.2. Mergers & Acquisitions

12.3. Product Launches

13. Competitive Landscape

13.1. Business Overview

13.2. Product Offerings

13.3. Recent Developments

13.4. Financials (As Reported)

13.5. Key Personnel

13.6. SWOT Analysis

13.6.1. CooperSurgical, Inc.

13.6.2. Centogene AG

13.6.3. Invitae Corporation

13.6.4. Illumina, Inc.

13.6.5. Myriad Genetics, Inc.,

13.6.6. Thermo Fisher Scientific Inc.

13.6.7. Laboratory Corporation of America Holdings

13.6.8. Quest Diagnostics

13.6.9. Natera, Inc

13.6.10. Eurofins Scientific SE

Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the Global Reproductive Genetics Market?

Increasing awareness and acceptance for genetic testing along with screening and rising emphasis on early detection and prevention, are some of the major factors driving the growth of global reproductive genetics market.

Who are the top players operating in the Global Reproductive Genetics Market?

CooperSurgical, Inc., Centogene AG, Invitae Corporation, Illumina, Inc.,Myriad Genetics, Inc., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Natera, Inc, Eurofins Scientific SE are some of the leading players operating in the Global Reproductive Genetics Market.

Which technology is expected to dominate the Global Reproductive Genetics Market in the forecast period?

The microarray technology is expected to dominate the global reproductive genetics market during the forecast period.

Which region is expected to account for the largest share in the Global Reproductive Genetics Market?

North America region is expected to hold the largest share in the Global Reproductive Genetics Market.

Related Reports

Sakshi Bajaal

Business Consultant

Talk To Analyst

Press Release

Reproductive Genetics Market to be dominated by Microarray type through 2028

Dec, 2022

Increasing demand for genetic testing and screening is expected to drive the growth of global reproductive genetics market in the forecast period, 2024-2028.

Buy Now